United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$4.4Mraised across 4 rounds since 2014, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
RA Capital Management
National Institutes of Health
North Carolina Biotechnology CenterSource recorded
RA Capital Management
Eshelman VenturesFrom a historical funding recordSEC filing: $3.4M sold, first sale Oct 2014
From a historical funding recordSEC filing: $100K sold, first sale Oct 2014
No investor was named in the report.
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
RA Capital ManagementNational Institutes of HealthNational Institute on AgingNorth Carolina Biotechnology CenterEshelman VenturesTerry EngleMissing a round, or an investor who was in one? Tell us.
Dignify Therapeutics's investors include RA Capital Management, National Institutes of Health, National Institute on Aging, North Carolina Biotechnology Center and Eshelman Ventures, and 1 more on record.
Dignify Therapeutics has raised $4.4M across 4 rounds since 2014.
Dignify Therapeutics's most recent round was a Grant of $1.2M in Sept 2024.
Dignify Therapeutics's largest round on record is $3.0M (Venture), in Feb 2015.
Dignify Therapeutics's first round on record, in Sept 2014, was backed by National Institutes of Health.
Dignify Therapeutics's latest named round is a Grant, in Sept 2024.
Dignify Therapeutics is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
